摘要
目的分析骨质疏松对经皮椎间孔镜下髓核摘除术治疗腰椎间盘突出症患者临床效果的影响。方法回顾性选取2020年1月至2023年1月在宁波市医疗中心李惠利医院行经皮椎间孔镜下髓核摘除术治疗的腰椎间盘突出症患者80例。腰椎骨密度检测结果显示39例患者伴有骨质疏松(骨质疏松组),另41例患者不伴有骨质疏松(非骨质疏松组)。观察两组患者术前及术后3、6、12个月时疼痛视觉模拟量表(VAS)评分、Oswestry功能障碍指数(ODI)和疗效(采用改良Macnab疗效评定标准评估)并作比较。结果两组患者术后3、6、12个月时VAS评分和ODI指数均明显低于术前(均P<0.05),骨质疏松组患者VAS评分和ODI在术后6、12个月时高于非骨质疏松组(均P<0.05);骨质疏松组患者术后3、6、12个月疗效较非骨质疏松组差(均P<0.05)。结论经皮椎间孔镜下髓核摘除术治疗腰椎间盘突出是一种可靠的治疗方式,但骨质疏松会影响治疗效果。
Objective To analyze the influence of osteoporosis on the treatment of lumbar disc herniation(LDH)by percutaneous endoscopic lumbar discectomy(PELD).Methods Eighty patients with LDH from January 2020 to January 2023 received PELD in Ningbo Medical Center Lihuili Hospital were selected.Based on lumbar vertebra bone mineral density(BMD)test,39 patients had osteoporosis(OP group)and 41 did not have(non-osteoporosis group).Pain Visual Analog Scale(VAS),Oswestry Disability Index(ODI)and efficacy(assessed by modified MacNab criteria)were recorded before surgery and 3,6,and 12 months after surgery.Results VAS and ODI scores at 3,6,12 months after surgery were significantly lower than those before surgery(all P<0.05).However,VAS and ODI scores in OP group were higher than those in non-osteoporosis group at 6,and 12 months after operation(all P<0.05).The efficacy of patients in the OP group at 3,6 and 12 months after surgery was lower than that of non-osteoporosis group(all P<0.05).Conclusion PELD is a reliable option for the treatment of LDH,while osteoporosis may affect the treatment effect.
作者
应永干
楼颖颖
李珊珊
YING Yonggan;LOU Yingying;LI Shanshan(Department of Pain,Ningbo Medical Center Lihuili Hospital,Ningbo 315000,China)
出处
《浙江医学》
2025年第12期1259-1262,1271,共5页
Zhejiang Medical Journal
基金
浙江省中医药科技计划项目(2024ZL947)。
关键词
骨质疏松
经皮椎间孔镜
腰椎间盘突出症
疗效影响
Osteoporosis
Percutaneous endoscopic lumbar discectomy
Lumbar disc herniation
Curative effect
